InduPro uses a proximity-guided platform to map the spatial arrangement of cell surface proteins and identify tumor-selective target pairs. Its lead candidate IDP-001 is a bispecific antibody-drug conjugate directed at EGFR and a novel tumor-associated proximity antigen. Headquartered in Seattle, Washington.